PP01.44 Long-Term Survival and Outcomes by Race from the Phase I/II trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced NSCLC: HCRN LUN13-175
| Autor: | Gentzler, R., Mohindra, N., Jalal, S., Reckamp, K., Hall, R., Hanna, N., Chae, Y., Koczywas, M., Helenowski, I., Patel, J. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology March 2023 18(3) Supplement:e29-e29 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|